Trials / Completed
CompletedNCT00966901
Photoirritation and Photoallergic Potential of a New Nicotine Patch
Assessment of Photoirritation and Photoallergic Potential of a Newly Developed Nicotine Transdermal Therapeutic System (TTS) After Single and Multiple Application and Multiple UV Exposure in Healthy Subjects. A Standard Photocontact Allergenicity Assay.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- McNeil AB · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
An evaluation of the effects of UV exposure following the use of a new nicotine patch.
Detailed description
An evaluation on the phototoxic potential of a newly developed nicotine patch after a single dose application followed by UV exposure, and an evaluation on the photoallergenic potential of the new nicotine patch after multiple dose applications followed by UV exposure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nicotine Patch | 25 mg nicotine patch applied on the assigned marked site on the lower back or buttock. Induction (23 days): six treatment applications for 24 h. Challenge (five days): one treatment application for 24 h. |
| DRUG | Placebo Patch | As a positive control, a placebo patch applied on the assigned marked site on the lower back or buttock. Induction (23 days): six treatment applications for 24 h. Challenge (five days): one treatment application for 24 h. |
| DRUG | No Patch Control | As a negative control, a marked site on the lower back or buttock was assigned as test area, but no patch was applied. |
| RADIATION | UVA and UVB irradiation | All three test sites exposed to UV radiation after patch removal. Induction: 10 J/cm2 UVA and 0.5 MED UVB, one treatment after first patch removal; and 3 MED UVB at the 5 following treatments. Challenge: 4 J/cm2 UVA and 0.5MED UVB, one treatment.( MED: Minimal Erythema Dose determined during screening) |
Timeline
- Start date
- 2005-08-01
- Primary completion
- 2005-10-01
- Completion
- 2005-10-01
- First posted
- 2009-08-27
- Last updated
- 2012-07-10
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00966901. Inclusion in this directory is not an endorsement.